A detailed history of State Board Of Administration Of Florida Retirement System transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 20,345 shares of AVXL stock, worth $113,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,345
Previous 18,295 11.21%
Holding current value
$113,932
Previous $93,000 8.6%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$3.39 - $5.02 $6,949 - $10,291
2,050 Added 11.21%
20,345 $85,000
Q1 2024

May 08, 2024

SELL
$4.55 - $6.75 $9,327 - $13,837
-2,050 Reduced 10.08%
18,295 $93,000
Q3 2023

Nov 08, 2023

BUY
$6.55 - $9.37 $2,685 - $3,841
410 Added 2.06%
20,345 $133,000
Q2 2023

Aug 11, 2023

BUY
$7.66 - $9.5 $12,562 - $15,580
1,640 Added 8.96%
19,935 $162,000
Q4 2022

Feb 07, 2023

BUY
$7.65 - $14.43 $3,060 - $5,772
400 Added 2.24%
18,295 $169,000
Q2 2022

Aug 05, 2022

BUY
$7.31 - $12.84 $73 - $128
10 Added 0.06%
17,895 $179,000
Q4 2021

Feb 08, 2022

BUY
$16.88 - $23.31 $17,622 - $24,335
1,044 Added 6.2%
17,885 $310,000
Q3 2021

Nov 08, 2021

SELL
$16.82 - $25.75 $200,460 - $306,888
-11,918 Reduced 41.44%
16,841 $302,000
Q2 2021

Aug 10, 2021

BUY
$10.16 - $28.86 $181,874 - $516,622
17,901 Added 164.86%
28,759 $657,000
Q2 2020

Aug 07, 2020

BUY
$2.62 - $5.2 $28,447 - $56,461
10,858 New
10,858 $53,000
Q2 2018

Aug 06, 2018

SELL
$2.08 - $4.26 $33,978 - $69,591
-16,336 Closed
0 $0
Q3 2017

Oct 31, 2017

BUY
$3.42 - $4.87 $55,869 - $79,556
16,336
16,336 $66,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $436M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.